Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898432-08-000016
Filing Date
2008-01-11
Accepted
2008-01-11 16:42:36
Documents
1
Period of Report
2008-01-09

Document Format Files

Seq Description Document Type Size
1 form4_ex.html 4  
1 form4_ex.xml 4 3470
  Complete submission text file 0000898432-08-000016.txt   5551
Mailing Address 2131 PALOMAR ROAD SUITE 300 CARLSBAD CA 92011
Business Address 2131 PALOMAR ROAD SUITE 300 CARLSBAD CA 92011 760-602-8422
Ardea Biosciences, Inc./DE (Issuer) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL ST STE 2105 BATON ROUGE LA 70801
Business Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL STREET STE 2105 BATON ROUGE LA 70801 2253447780
ANDREEFF DANE (Reporting) CIK: 0001201810 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33734 | Film No.: 08526664